Drug Profile
Research programme: progesterone receptor modulators - Ligand/Organon
Alternative Names: ORG-44664; ORG-841Latest Information Update: 05 Dec 2007
Price :
$50
*
At a glance
- Originator Ligand Pharmaceuticals; Organon
- Developer Ligand Pharmaceuticals
- Class Small molecules
- Mechanism of Action Progesterone receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female genital diseases; Female infertility; Menopausal syndrome; Pregnancy
Most Recent Events
- 23 Jun 2004 This programme is still in active development - [(BIO 2004 Annual International Convention (BIO-2004)]
- 13 Jun 2003 Preclinical development in Female infertility in USA (unspecified route)
- 13 Jun 2003 Preclinical development in Menopausal syndrome in USA (unspecified route)